This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Ovarian Cancer
  • /
  • Rucaparib in ovarian cancer: extending the use of ...
Journal

Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease

Read time: 1 mins
Published:1st Dec 2018
Author: Dal Molin GZ, Westin SN, Coleman RL.
Source: Future Oncology
Availability: Pay for access, or by subscription
Ref.:Future Oncol. 2018;14(30):3101-3110.
DOI:10.2217/fon-2018-0215
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest